How long can I stay on 15mg Mounjaro — and is there a cut-off?

The myth: 15mg is a short course you eventually come off

A question our prescribers hear most weeks is some version of: "Once I reach 15mg, how long before I have to stop?" The assumption behind it (that reaching the top dose signals an end point) is understandable but incorrect. Mounjaro is licensed for chronic weight management, which means it is designed to be taken for as long as it is helping and is clinically appropriate. There is no licensed duration ceiling written into the Mounjaro SmPC the way some other medicines have one.

The confusion often comes from mixing up dose escalation with treatment duration. The titration schedule (starting at 2.5mg and working upward through 5mg, 7.5mg, 10mg, 12.5mg and finally 15mg) exists to let your body adjust gradually and reduce early side effects. Reaching 15mg simply means you have completed that escalation. What happens next is a conversation with your prescriber, not an automatic exit. For more on how the earlier steps work, the 5mg Mounjaro dose guide covers that part of the journey in detail.

SURMOUNT-1, the landmark 72-week trial published in the New England Journal of Medicine, followed participants at 15mg for the full trial duration without a scheduled stop point. Average weight reduction at 15mg reached around 20–21%, results that held because people continued the treatment, not because they came off it at a target date.

What NICE guidance actually says about reviewing whether to continue

The closest thing to a "review trigger" in UK clinical guidance comes from NICE technology appraisal TA1026, which recommends that prescribers assess progress after six months at the highest tolerated dose. If weight loss at that point is below 5% of starting body weight, continuing treatment should be discussed and may not be recommended. This is a clinical safety net, not a time limit, if you are losing weight and tolerating the medicine well, there is no guidance-mandated reason to stop.

That 5% benchmark matters because it tells your prescriber whether the treatment is working for your biology. Some people respond strongly at lower doses; others need 15mg before meaningful progress starts. Neither pattern is a failure. The prescriber's job at every repeat review is to weigh benefit against any ongoing side effects, look at where your weight is now, and decide whether continuing makes sense for you specifically.

It is also worth knowing that the NICE criteria for starting treatment are distinct from the criteria for continuing it. The starting eligibility question (BMI, comorbidities, background) is separate from the continuation question, which is purely about response and tolerability. You can read more about the broader Mounjaro treatment picture on the Mounjaro overview page, or explore weight loss treatment options if you are still weighing up which route suits you.

Practical things that can change how long you stay at 15mg

Several real-world factors shape how long any individual stays at 15mg. The first is tolerability. At the top dose, gastrointestinal side effects (nausea, loose stools, reflux, reduced appetite) can be more pronounced for some people than at lower doses. If side effects are persistent and disruptive, a prescriber may recommend stepping back to 12.5mg rather than continuing at 15mg. That is a clinical adjustment, not a treatment failure, and the guide on how long to stay at 5mg gives useful context on how those earlier dose decisions are made.

The second factor is weight trajectory. If your weight loss has plateaued at 15mg and you have been at that dose for some months, your prescriber will review whether ongoing treatment continues to offer meaningful benefit. Weight management medicines work best alongside dietary changes and increased activity; if those elements are in place and progress has genuinely stalled, it is a conversation worth having rather than continuing on autopilot.

Cost is also a real consideration for many people. Private tirzepatide treatment in the UK is priced per pen, and the highest dose pens carry the highest price. If you are also trying to work out what your dose translates to in volume terms, our page explaining how many mg 70 units of tirzepatide equates to can help clarify the numbers. The Mounjaro price comparison guide covers what drives those costs and what a legitimate price should include. At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed, no auto-renewals, no subscription that ships without a clinical check.

Finally, life circumstances change. People may pause treatment around surgery (your anaesthetist and surgical team need to know you are taking a GLP-1 medicine), pregnancy planning, or breastfeeding, none of these are appropriate periods to continue tirzepatide. The frequently asked questions page covers several of these pauses in more detail, and the NHS medicines information on tirzepatide explains the clinical picture in patient-friendly language.

If you want to understand how the dose journey looks from the very beginning, the page on how long to stay at 2.5mg is a useful starting point. And if you are already in treatment and have questions about what comes next, our prescribers are available seven days a week through aftercare.